Search results for: 'formulation development'

The personal care and beauty industry is undergoing a significant transformation driven by resource efficiency, consumer demand, and a focus on sustainability. Traditionally, water has been a dominant ingredient in personal care and cosmetics products, comprising up to 60 to 95% of the formulations in products such as shampoos and creams, acting as...

AI-enhanced formulation transforms how advanced materials are designed, optimized, and commercialized, shifting from empirical experimentation to predictive, data-driven discovery. By combining AI, ML, and materials informatics, formulators can simulate and optimize complex multi-component systems, accelerating performance tuning, improving sustain...

With persistent geopolitical tensions and the resultant trade fragmentation continuing to shape the global economy, policy priorities among countries advanced and emerging are shifting toward macroeconomic frameworks that will insulate them from external shocks. Incremental reforms that support sustainability and Industry 5.0 practices will have pr...

Small molecules, which are the leading drug class across indications, face several issues that threaten their drug delivery efficacy. They suffer from off-target effects, poor bioavailability, low solubility, systemic toxicity, and poor permeability. While the small molecule drug development pipeline remains a leading therapeutic class, it is essen...

Immuno-oncology (I-O) therapies target tumors by harnessing the host s immune system. With the growing incidence and prevalence of various types of aggressive and refractory cancers, the next-generation I-O therapy pipeline has witnessed significant growth. Chimeric antigen receptor (CAR)-T cell therapy and tumor-targeted antibody therapies, includ...

Microbiome research is on the rise following technological advancements and significant cost reductions in microbiome analysis. Research has unlocked the potential of microbiome in medical use cases, yielding tremendous insights on its nature, interactions, and impact within a host and in an external environment. Advanced studies on the role of mic...

Biologics, particularly peptide and protein therapies, are a rapidly growing therapeutic area because they can target complex biological pathways with high efficacy. These therapies are becoming important in oncology, metabolic disease, and autoimmune conditions supported by the growing global disease burden and growth in areas such as GLP-1s and m...

The growing global demand for sustainable and ethical food sources has led to significant advancements in alternative proteins. From plant-based proteins to cellular agriculture and novel fermentation techniques, researchers and industry pioneers are leveraging biotechnology, data analytics, and process optimization to enhance the efficiency and sc...

By 2023, biologics constituted 44% of the therapeutic pipeline, with antibodies and recombinant proteins as leading categories. Nevertheless, advancements in these fields decelerated, with most of the expansion happening in heterologous cell treatments, synthetic nucleic acids, and viruses. The global biologics pipeline will shift toward more compl...